Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells

J Neurooncol. 2016 May;128(1):9-19. doi: 10.1007/s11060-016-2076-2. Epub 2016 Feb 22.

Abstract

The most aggressive type of brain tumor is glioblastoma multiforme, which to date remains incurable. Thuja occidentalis is used in homeopathy for the treatment of cancer, however, its mechanism of action remains unknown. We set out to study the effects of thujone fractions of Thuja on glioblastoma using in vitro and in vivo models. We found that the α/ β-thujone fraction decrease the cell viability and exhibit a potent anti-proliferative, pro-apoptotic and anti-angiogenic effects in vitro. In vivo assays showed that α /β-thujone promotes the regression of neoplasia and inhibits the angiogenic markers VEGF, Ang-4 and CD31 into the tumor.

Keywords: Angiogenesis; Angiopoietin-4; Apoptosis; Glioblastoma multiforme; Thuja occidentalis; α / β-Thujone fraction.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Bicyclic Monoterpenes
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Glioblastoma / blood supply
  • Glioblastoma / drug therapy*
  • Glioblastoma / pathology
  • Glioblastoma / physiopathology
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / physiology
  • Humans
  • Male
  • Monoterpenes / pharmacology*
  • Neoplasm Transplantation
  • Phytotherapy*
  • Plant Extracts / pharmacology*
  • Rats, Sprague-Dawley
  • Thuja*

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Bicyclic Monoterpenes
  • Monoterpenes
  • Plant Extracts
  • beta-thujone